Ergomed PLC | Cash Flow

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,778.00
777.00
2,072.00
223.00
4,447.00
10,768
Depreciation, Depletion & Amortization
63.00
519.00
713.00
1,027.00
1,626.00
2,534
Other Funds
-
1,869.00
-
-
-
6,811
Funds from Operations
1,741.00
1,574.00
2,150.00
1,546.00
981.00
1,423
Changes in Working Capital
360.00
1,039.00
1,886.00
3,920.00
954.00
2,468
Net Operating Cash Flow
1,381.00
535.00
264.00
2,374.00
27.00
1,045
Capital Expenditures
70.00
146.00
555.00
1,109.00
1,425.00
Sale of Fixed Assets & Businesses
-
11.00
2.00
31.00
11.00
Purchase/Sale of Investments
-
40.00
1.00
-
-
Net Investing Cash Flow
701.00
7,021.00
866.00
5,833.00
3,919.00
Issuance/Reduction of Debt, Net
66.00
19.00
-
5.00
10.00
Net Financing Cash Flow
66.00
9,112.00
-
8,657.00
2,686.00
Net Change in Cash
1,505.00
2,626.00
602.00
450.00
1,206.00
Free Cash Flow
1,311.00
473.00
6.00
2,778.00
694.00
Net Assets from Acquisitions
669.00
6,846.00
312.00
4,755.00
1,946.00
Other Sources
38.00
-
-
-
-
Change in Capital Stock
-
11,000.00
-
8,662.00
2,676.00
Exchange Rate Effect
891.00
-
-
-
-
Other Uses
-
-
-
-
559.00

About Ergomed

View Profile
Address
The Surrey Research Park
Guildford Surrey GU2 7YD
United Kingdom
Employees -
Website http://ergomedplc.com/
Updated 07/08/2019
Ergomed Plc is a clinical development company. The company is engaged in the provision of services to the pharmaceutical industry and the development of orphan drugs. It focuses on the development of oncology, neurology and immunology drugs.